<HTML>
<HEAD>
<TITLE>Filed by Bowne Pure Compliance</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">
<DIV style="font-size: 10pt">
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 2pt solid">&nbsp;</DIV>
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 1pt solid">&nbsp;</DIV>

<P style="font-size: 14pt" align="center"><B>UNITED STATES<BR>
SECURITIES AND
EXCHANGE COMMISSION<BR>
<FONT style="font-size: 12pt">Washington, D.C. 20549
</FONT></B>

<P style="font-size: 18pt" align="center"><B>FORM 8-K</B>

<P style="font-size: 12pt" align="center"><B>CURRENT REPORT<BR>
Pursuant to
Section 13 OR 15(d) of The Securities Exchange Act of 1934</B>

<P style="font-size: 10pt" align="center"><B>Date of Report (Date of earliest
event reported): September 15, 2008</B>

<P style="font-size: 24pt" align="center"><B>CLEANTECH BIOFUELS,
INC.<BR>
</B><FONT style="font-size: 10pt">(Exact name of registrant as
specified in its charter) </FONT>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="100%" border="0">

 <TR>
  <TD width="32%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="33%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="32%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>Delaware</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>333-145939</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>33-0754902</B></TD>
 </TR>
 <TR valign="top">
  <TD>(State or other Jurisdiction of Incorporation)</TD>
  <TD>&nbsp;</TD>
  <TD>(Commission File Number)</TD>
  <TD>&nbsp;</TD>
  <TD>(IRS Employer Identification No.)</TD>
 </TR>

</TABLE>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="100%" border="0">

 <TR>
  <TD width="49%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="49%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>7386 Pershing Ave, University
City, Missouri<BR>
</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>63130</B></TD>
 </TR>
 <TR valign="top">
  <TD>(Address of Principal Executive Offices)</TD>
  <TD>&nbsp;</TD>
  <TD>(Zip Code)</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="center">Registrant&#8217;s telephone number,
including area code: <B>(314) 862-8670</B>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="30%" border="0">

 <TR>
  <TD width="100%">&nbsp;</TD>
 </TR>
 <TR>
  <TD style="border-bottom: #000000 1px solid" nowrap><B>N/A<BR>
</B></TD>
 </TR>
 <TR>
  <TD nowrap>(Former name or former address if changed since last report.)</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="left">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:

<P style="font-size: 10pt" align="left"><FONT face="Wingdings">o</FONT> Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)<BR>
<BR>
<FONT face="Wingdings">o</FONT> Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<BR>
<BR>
<FONT
face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<BR>
<BR>
<FONT
face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<BR>


<DIV
style="margin-top: 10pt; font-size: 1pt; width: 100%; border-bottom: black 1pt solid">&nbsp;</DIV>
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 2pt solid">&nbsp;</DIV>
</DIV>

<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="justify"><B>Section&nbsp;1 &#8211;
Registrant&#8217;s Business and Operations</B>

<P style="font-size: 10pt" align="justify"><B>Item&nbsp;1.01. Entry into a
Material Definitive Agreement.</B>

<P style="font-size: 10pt" align="justify">On September&nbsp;15, 2008,
CleanTech Biofuels, Inc. (the &#8220;Company&#8221;) consummated the
acquisition of Biomass North America Licensing, Inc. (&#8220;Biomass&#8221;)
pursuant to a merger between Biomass and a wholly-owned subsidiary of the
Company (with Biomass as the surviving subsidiary of the Company) in accordance
with an Agreement and Plan of Merger (&#8220;Agreement&#8221;) by and between
the Company and Biomass. The merger consideration is further described in
Item&nbsp;2.03 and Item&nbsp;3.02 of this Current Report on Form 8-K (the
&#8220;Form 8-K&#8221;) and such disclosure is incorporated herein by this
reference. The Agreement, previously announced by the Company on July&nbsp;15,
2008, was filed as an exhibit to the Company&#8217;s Quarterly Report on Form
10-Q for the quarterly period ended June&nbsp;30, 2008, which was filed on
August&nbsp;13, 2008, and is incorporated hereto by this reference. In
addition, the foregoing description is qualified by reference to such exhibit.

<P style="font-size: 10pt" align="justify">By virtue of the merger, the Company
acquired a license agreement pursuant to which the Company holds a license in
the United States and Canada to use patent pending technology owned by Biomass
North America, L.L.C., the former parent of Biomass (the
&#8220;Licensor&#8221;), to clean and separate municipal solid waste (the
&#8220;Technology&#8221;). The license requires that the Company pay a royalty
in the amount of $1.00 per ton of bone-dry biomass produced using the
Technology. The license agreement is for a term of 21&nbsp;years or the life of
any patent issued for the Technology. The Company has an exclusive license in
the United States and Canada to use the Technology, except that a principal
owner of the Licensor has the right of first offer to manage and operate with
respect to any development commenced using the licensed technology within 100
miles of the City of Chicago, Illinois. The license agreement further provides
that Biomass and Licensor will work in good faith to complete a commercial
development in the City of Chicago using the licensed technology.

<P style="font-size: 10pt" align="justify"><B>Section&nbsp;2 &#8211; Financial
Information</B>

<P style="font-size: 10pt" align="justify"><B>Item&nbsp;2.03. Creation of a
Direct Financial Obligation or an Obligation under an Off-Balance Sheet
Arrangement of a Registrant.</B>

<P style="font-size: 10pt" align="justify">Pursuant to the terms of the
Agreement mentioned in Item&nbsp;1.01 of this Form 8-K, upon closing of the
merger on September 15, 2008, the Company paid $20,000 in cash and issued a
nine-month promissory note in the original principal amount of $80,000 bearing
interest at an annual rate of 6% (the &#8220;Note&#8221;) to a shareholder of
the Licensor. If the amount due under the Note is not paid during the term of
the Note, the holder has a right to receive 120,000 shares of the
Company&#8217;s common stock, par value $.001 (&#8220;Common Stock&#8221;), in
addition to receiving the principal and interest due on the Note.


<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="justify"><B>Section&nbsp;3 &#8211; Securities
and Trading Markets</B>

<P style="font-size: 10pt" align="justify"><B>Item&nbsp;3.02. Unregistered
Sales of Equity Securities.</B>

<P style="font-size: 10pt" align="justify">Pursuant to the terms of the
Agreement mentioned in Item&nbsp;1.01 of this Form 8-K, upon closing of the
merger on September 15, 2008, the Company issued 1,895,000 shares of the
Company&#8217;s Common Stock to the four shareholders of the Licensor and
deposited an additional 4,000,000 shares of the Company&#8217;s Common Stock
into an escrow account (collectively, the &#8220;Shares&#8221;). The Shares
were issued as part of the merger consideration received by the shareholders of
the Licensor. The 4,000,000 shares of Common Stock held in escrow will be
released to these shareholders if and when the Company commences a commercial
development that utilizes the Technology. The Shares were issued to the four
shareholders of the Licensor pursuant to Section&nbsp;4(2) of the Securities
Act of 1933, as amended.

<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="center"><B>SIGNATURES</B>

<P style="font-size: 10pt" align="justify">Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned thereunto duly authorized.
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%"
border="0">
<!-- Begin Table Head -->

 <TR valign="bottom">
  <TD width="40%">&nbsp;</TD>
  <TD width="5%">&nbsp;</TD>
  <TD width="5%">&nbsp;</TD>
  <TD width="5%">&nbsp;</TD>
  <TD width="45%">&nbsp;</TD>
 </TR>

 <TR style="font-size: 10pt" valign="bottom">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD nowrap align="left" colspan="3"><B>CLEANTECH BIOFUELS, INC.</B></TD>
 </TR>
<!-- End Table Head -->

<!-- Begin Table Body -->
 <TR valign="bottom">
  <TD valign="top"><DIV style="margin-left: 0px; text-indent: 0px">&nbsp;</DIV></TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">&nbsp; </TD>
 </TR>

 <TR valign="bottom">
  <TD valign="top">Date: September&nbsp;19, 2008&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">By:&nbsp;&nbsp;</TD>
  <TD valign="top" align="left" colspan="2" style="border-bottom: 1px solid #000000">/s/ Edward P. Hennessey&nbsp;</TD>
 </TR>

 <TR valign="bottom">
  <TD valign="top"><DIV style="margin-left: 0px; text-indent: 0px">&nbsp;</DIV></TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Name:&nbsp;&nbsp; </TD>
  <TD valign="top" align="left">Edward P. Hennessey&nbsp;</TD>
 </TR>

 <TR valign="bottom">
  <TD valign="top"><DIV style="margin-left: 0px; text-indent: 0px">&nbsp;</DIV></TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Title:&nbsp;&nbsp; </TD>
  <TD valign="top" align="left">Chief Executive Officer and President&nbsp;</TD>
 </TR>
<!-- End Table Body -->

</TABLE>
</DIV>

<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">4
</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "c75407e8vk.htm", "description": "FORM 8-K", "secsgml_size_bytes": 11257}]
{"company-data": {"conformed-name": "CleanTech Biofuels, Inc.", "cik": "0001411036", "assigned-sic": "2860", "irs-number": "330754902"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-145939", "film-number": "081079540"}, "business-address": {"street1": "7386 PERSHING AVE.", "city": "ST. LOUIS", "state": "MO", "zip": "63130", "phone": "314-802-8670"}, "mail-address": {"street1": "7386 PERSHING AVE.", "city": "ST. LOUIS", "state": "MO", "zip": "63130"}}
Filed by Bowne Pure Compliance
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported): September 15, 2008
CLEANTECH BIOFUELS,
INC.
(Exact name of registrant as
specified in its charter)
Delaware
333-145939
33-0754902
(State or other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
7386 Pershing Ave, University
City, Missouri
63130
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number,
including area code:
(314) 862-8670
N/A
(Former name or former address if changed since last report.)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Section 1 –
Registrant's Business and Operations
Item 1.01. Entry into a
Material Definitive Agreement.
On September 15, 2008,
CleanTech Biofuels, Inc. (the "Company") consummated the
acquisition of Biomass North America Licensing, Inc. ("Biomass")
pursuant to a merger between Biomass and a wholly-owned subsidiary of the
Company (with Biomass as the surviving subsidiary of the Company) in accordance
with an Agreement and Plan of Merger ("Agreement") by and between
the Company and Biomass. The merger consideration is further described in
Item 2.03 and Item 3.02 of this Current Report on Form 8-K (the
"Form 8-K") and such disclosure is incorporated herein by this
reference. The Agreement, previously announced by the Company on July 15,
2008, was filed as an exhibit to the Company's Quarterly Report on Form
10-Q for the quarterly period ended June 30, 2008, which was filed on
August 13, 2008, and is incorporated hereto by this reference. In
addition, the foregoing description is qualified by reference to such exhibit.
By virtue of the merger, the Company
acquired a license agreement pursuant to which the Company holds a license in
the United States and Canada to use patent pending technology owned by Biomass
North America, L.L.C., the former parent of Biomass (the
"Licensor"), to clean and separate municipal solid waste (the
"Technology"). The license requires that the Company pay a royalty
in the amount of $1.00 per ton of bone-dry biomass produced using the
Technology. The license agreement is for a term of 21 years or the life of
any patent issued for the Technology. The Company has an exclusive license in
the United States and Canada to use the Technology, except that a principal
owner of the Licensor has the right of first offer to manage and operate with
respect to any development commenced using the licensed technology within 100
miles of the City of Chicago, Illinois. The license agreement further provides
that Biomass and Licensor will work in good faith to complete a commercial
development in the City of Chicago using the licensed technology.
Section 2 – Financial
Information
Item 2.03. Creation of a
Direct Financial Obligation or an Obligation under an Off-Balance Sheet
Arrangement of a Registrant.
Pursuant to the terms of the
Agreement mentioned in Item 1.01 of this Form 8-K, upon closing of the
merger on September 15, 2008, the Company paid $20,000 in cash and issued a
nine-month promissory note in the original principal amount of $80,000 bearing
interest at an annual rate of 6% (the "Note") to a shareholder of
the Licensor. If the amount due under the Note is not paid during the term of
the Note, the holder has a right to receive 120,000 shares of the
Company's common stock, par value $.001 ("Common Stock"), in
addition to receiving the principal and interest due on the Note.
Section 3 – Securities
and Trading Markets
Item 3.02. Unregistered
Sales of Equity Securities.
Pursuant to the terms of the
Agreement mentioned in Item 1.01 of this Form 8-K, upon closing of the
merger on September 15, 2008, the Company issued 1,895,000 shares of the
Company's Common Stock to the four shareholders of the Licensor and
deposited an additional 4,000,000 shares of the Company's Common Stock
into an escrow account (collectively, the "Shares"). The Shares
were issued as part of the merger consideration received by the shareholders of
the Licensor. The 4,000,000 shares of Common Stock held in escrow will be
released to these shareholders if and when the Company commences a commercial
development that utilizes the Technology. The Shares were issued to the four
shareholders of the Licensor pursuant to Section 4(2) of the Securities
Act of 1933, as amended.
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned thereunto duly authorized.
CLEANTECH BIOFUELS, INC.
Date: September 19, 2008
By:
/s/ Edward P. Hennessey
Name:
Edward P. Hennessey
Title:
Chief Executive Officer and President